TrialBritish journal of clinical pharmacology1999

Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity.

N Brynne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.